Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 2
1972 4
1973 1
1974 1
1975 1
1976 5
1977 4
1978 3
1979 4
1980 1
1981 1
1982 1
1983 2
1984 2
1986 2
1987 1
1989 1
1992 1
1995 1
1999 1
2000 1
2003 1
2005 1
2009 2
2010 1
2011 1
2012 3
2013 2
2014 5
2015 4
2016 1
2017 2
2018 1
2019 1
2021 2
2022 3
2023 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
ESVM Guideline on peripheral arterial disease.
Frank U, Nikol S, Belch J, Boc V, Brodmann M, Carpentier PH, Chraim A, Canning C, Dimakakos E, Gottsäter A, Heiss C, Mazzolai L, Madaric J, Olinic DM, Pécsvárady Z, Poredoš P, Quéré I, Roztocil K, Stanek A, Vasic D, Visonà A, Wautrecht JC, Bulvas M, Colgan MP, Dorigo W, Houston G, Kahan T, Lawall H, Lindstedt I, Mahe G, Martini R, Pernod G, Przywara S, Righini M, Schlager O, Terlecki P. Frank U, et al. Among authors: roztocil k. Vasa. 2019 Sep;48(Suppl 102):1-79. doi: 10.1024/0301-1526/a000834. Vasa. 2019. PMID: 31789115 Free article. No abstract available.
ESVM guidelines - the diagnosis and management of Raynaud's phenomenon.
Belch J, Carlizza A, Carpentier PH, Constans J, Khan F, Wautrecht JC, Visona A, Heiss C, Brodeman M, Pécsvárady Z, Roztocil K, Colgan MP, Vasic D, Gottsäter A, Amann-Vesti B, Chraim A, Poredoš P, Olinic DM, Madaric J, Nikol S, Herrick AL, Sprynger M, Klein-Weigel P, Hafner F, Staub D, Zeman Z. Belch J, et al. Among authors: roztocil k. Vasa. 2017 Oct;46(6):413-423. doi: 10.1024/0301-1526/a000661. Epub 2017 Sep 12. Vasa. 2017. PMID: 28895508 Free article. Review.
Superficial vein thrombosis: a consensus statement.
Kalodiki E, Stvrtinova V, Allegra C, Andreozzi G, Antignani PL, Avram R, Brkljacic B, Cadariou F, Dzsinich C, Fareed J, Gaspar L, Geroulakos G, Jawien A, Kozak M, Lattimer CR, Minar E, Partsch H, Passariello F, Patel M, Pécsvárady Z, Poredos P, Roztocil K, Scuderi A, Sparovec M, Szostek M, Skorski M. Kalodiki E, et al. Among authors: roztocil k. Int Angiol. 2012 Jun;31(3):203-16. Int Angiol. 2012. PMID: 22634973 No abstract available.
Chronic Venous Disease and Its Intersections With Diabetes Mellitus.
Jarošíková R, Roztočil K, Husáková J, Dubský M, Bém R, Wosková V, Fejfarová V. Jarošíková R, et al. Among authors: roztocil k. Physiol Res. 2023 Jul 14;72(3):280-286. doi: 10.33549/physiolres.935033. Physiol Res. 2023. PMID: 37449742 Free PMC article. Review.
Medical management of patients with peripheral arterial disease.
Poredoš P, Jezovnik M, Kalodiki E, Andreozzi G, Antignani PL, Clement D, Comerota A, Fareed J, Fletcher J, Fras Z, Griffin M, Markel A, Martini R, Mignano A, Nicolaides A, Novo G, Novo S, Roztočil K, Visona A. Poredoš P, et al. Among authors: roztocil k. Int Angiol. 2015 Feb;34(1):75-93. Epub 2014 Jun 11. Int Angiol. 2015. PMID: 24916346 Review.
Requirements for angiology/vascular medicine.
Catalano M, Poredos P, Brodmann M, Wautrecht JC, Carpentier P, Roztocil K, Nikol S, Diamantopoulos E, Pecsvarady Z, Carlizza A, Sieron A, Stanek A, Olinic D, Stvrtinova V, Kozak M, Agewall S, Gallino A, Jaeger KA, Fitzgerald P, Colgan MP. Catalano M, et al. Among authors: roztocil k. Int Angiol. 2013 Dec;32(6):608-12. Int Angiol. 2013. PMID: 24212296 No abstract available.
Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations-State-of-the-Art.
Dimakakos E, Gomatou G, Catalano M, Olinic DM, Spyropoulos AC, Falanga A, Maraveyas A, Liew A, Schulman S, Belch J, Gerotziafas G, Marschang P, Cosmi B, Spaak J, Syrigos K; CANCER-COVID-19 THROMBOSIS COLLABORATIVE GROUP, endorsed by VAS-European Independent Foundation in Angiology/Vascular Medicine, UEMS Vascular Medicine/Angiology and European Society of Vascular Medicine, and supported by the Balkan Working Group for Prevention and Treatment of Venous Thromboembolism and Hellenic Association of Lung Cancer. Dimakakos E, et al. Anticancer Res. 2022 Jul;42(7):3261-3274. doi: 10.21873/anticanres.15815. Anticancer Res. 2022. PMID: 35790272 Review.
Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization.
Hess CN, Szarek M, Anand SS, Bauersachs RM, Patel MR, Debus ES, Nehler MR, Capell WH, Beckman JA, Piazza G, Henkin S, Bura-Rivière A, Lawall H, Roztocil K, Hsia J, Muehlhofer E, Berkowitz SD, Haskell LP, Bonaca MP. Hess CN, et al. Among authors: roztocil k. JAMA Netw Open. 2022 Jun 1;5(6):e2215580. doi: 10.1001/jamanetworkopen.2022.15580. JAMA Netw Open. 2022. PMID: 35731517 Free PMC article. Clinical Trial.
69 results